Clinical Trials on Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation
Total 1149 results
-
Emory UniversityTerminatedBladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Squamous Cell Carcinoma of the BladderUnited States
-
Lipac Oncology LLCTesoRx Pharma, LLCCompletedUrologic Neoplasms | Urogenital Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Non-Muscle Invasive Bladder Cancer | Urinary Bladder | Bladder Cancer Cell TransitionalUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Astellas Pharma US, Inc.; Seagen Inc.RecruitingUrothelial CarcinomaUnited States
-
PfizerMerck KGaA, Darmstadt, GermanyActive, not recruiting
-
The Netherlands Cancer InstituteBristol-Myers SquibbCompletedUrothelial CarcinomaNetherlands
-
Daiichi Sankyo, Inc.Bristol-Myers Squibb; AstraZenecaActive, not recruitingBreast Cancer | Urothelial CarcinomaUnited States, Spain, Italy, Belgium, France, Germany, United Kingdom
-
DendreonTerminatedUrothelial CarcinomaUnited States
-
European Organisation for Research and Treatment...National Cancer Institute (NCI); NCIC Clinical Trials Group; Institute of Cancer... and other collaboratorsCompletedStage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder
-
Sanjay Gandhi Postgraduate Institute of Medical...CompletedSurvival | Gall Bladder Carcinoma
-
National Cancer Institute (NCI)TerminatedBladder Carcinoma | Recurrent Bladder CarcinomaUnited States
-
Queen Mary University of LondonNot yet recruitingTransitional Cell Carcinoma | Bladder Cancer
-
Queen Mary University of LondonHoffmann-La RocheUnknownBladder CancerUnited Kingdom, France, Spain, Netherlands
-
Merck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)CompletedCarcinoma, Transitional Cell | Bladder NeoplasmsUnited States
-
Zetiq TechnologiesUnknownEvaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine CytologyBladder Cancer Transitional Cell CarcinomaIsrael
-
Anchiano Therapeutics Israel Ltd.CompletedTransitional Cell Carcinoma of BladderIsrael
-
Roswell Park Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI)TerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage 0 Bladder Cancer | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Yale UniversityBayerCompleted
-
Shanghai Jiao Tong University School of MedicineShanghai 10th People's Hospital; China-Japan Union Hospital, Jilin University; Ganzhou City People's HospitalRecruiting
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingStage IV Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Stage IVB Bladder Cancer AJCC v8 | Bladder Urothelial CarcinomaUnited States
-
Vyriad, Inc.Mayo ClinicCompletedUrothelial CarcinomaUnited States
-
University of British ColumbiaRecruitingTransitional Cell Cancer of the Renal Pelvis and Ureter | Urothelial Carcinoma of the Renal Pelvis and UreterCanada
-
Fujian Medical UniversityNot yet recruitingAdvanced Gastric Carcinoma | Neoadjuvant Immunotherapy | CD8+ Tumor Infiltrating Lymphocytes
-
The Methodist Hospital Research InstituteActive, not recruitingNon-Small Cell Lung Cancer | DNA Repair-Deficiency Disorders | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma Bladder | Classical Hodgkin Lymphoma | Malignant MelanomaUnited States
-
M.D. Anderson Cancer CenterCompletedBladder CancerUnited States
-
Case Comprehensive Cancer CenterPfizerTerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
Chunguang yang (101937)RecruitingUrothelial Carcinoma | Radical CystectomyChina
-
Indiana UniversityTerminatedProstate Cancer | Urothelial CarcinomaUnited States
-
Fidia Farmaceutici s.p.a.CompletedONCOFID-P-B in the Intravescical Therapy of Patients With Non-muscle Invasive Cancer of the Bladder.Non-Invasive Papillary Carcinoma of BladderSpain, Germany, Italy
-
Princess Al-Johara Al-Ibrahim Cancer Research CenterCompletedTransitional Cell Carcinoma of the BladderSaudi Arabia
-
University of Southern CaliforniaNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
IO BiotechMerck Sharp & Dohme LLC; Theradex; Almac; NeoGenomicsRecruitingHead and Neck Squamous Cell Carcinoma | Urothelial Carcinoma Bladder | Lung Cancer Non Small CellUnited States, Spain, United Kingdom
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, AustraliaCompletedTransitional Cell Carcinoma of Urinary BladderAustralia, New Zealand
-
Noah Hahn, M.D.Pfizer; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma of the BladderUnited States, United Kingdom
-
Hoosier Cancer Research NetworkBristol-Myers SquibbCompletedTransitional Cell Carcinoma of the BladderUnited States
-
University of Michigan Rogel Cancer CenterTerminatedProstate Cancer | Bladder Cancer | Urothelial Carcinoma | Non-Small-Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
Assiut UniversityNot yet recruitingUrinary Bladder Squamous Cell Carcinoma
-
AstraZenecaEnrolling by invitationCancerUnited States, France, Italy, Spain, United Kingdom, Belgium, Canada, Poland, Thailand, Vietnam, Germany, Korea, Republic of, Brazil, Hungary, India, Japan, Russian Federation, Turkey, China, Malaysia, Taiwan, Australia, Ukraine, Bulg... and more
-
Oncolytics BiotechWithdrawnMuscle-invasive Transitional Cell Carcinoma of the Bladder
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyNot yet recruitingUrothelial CarcinomaUnited States, Germany
-
Seagen Inc.Merck Sharp & Dohme LLC; RemeGen Co., Ltd.RecruitingUrothelial CarcinomaUnited States, Canada, Taiwan, Australia, Singapore
-
Seagen Inc.RecruitingUrothelial CarcinomaUnited States, France
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingUrothelial CarcinomaUnited States, Canada, United Kingdom, Japan, Australia, Argentina, Chile, Israel, Belgium
-
BayerActive, not recruitingUrothelial CarcinomaUnited States, Korea, Republic of, Japan, Germany, Italy, Spain, Austria, France
-
Hoffmann-La RocheCompletedUrothelial CarcinomaSpain, United States, Korea, Republic of, Canada, United Kingdom, Czechia, Australia, Belgium, Brazil, China, Estonia, Finland, Greece, Hong Kong, Italy, Poland, Portugal, Slovenia, Mexico, Georgia, Russian Federation, Singapore, Th... and more
-
University of OklahomaEMD Serono; Aravive, Inc.Active, not recruitingUrothelial CarcinomaUnited States
-
Basilea PharmaceuticaCompletedUrothelial CarcinomaUnited Kingdom, Korea, Republic of, Italy, Canada, France, Spain, Germany, United States, Hungary, Australia, Poland, Switzerland, Czechia, Austria
-
Eli Lilly and CompanyCompletedUrothelial CarcinomaSpain, United States, Poland, Romania, Taiwan, Ukraine, Netherlands, Mexico, Japan, France, Germany, Belgium, Greece, Russian Federation, Turkey, Canada, Israel, Italy, United Kingdom, Denmark, Korea, Republic of, Australia, Hungary